General Archive

-
ArticlesUnveiling the future of cell and gene therapies in the UK
In recent years, cell and gene therapies have been advancing at lightning speed, offering new hope to patients. However, there’s…
-
News releasesLifeArc and the Francis Crick Institute partner with five African research institutions to support scientists
The Crick Africa Network (CAN) is set to extend for a further five years, supporting more young African scientists to…
-
News releasesLifeArc joins Infection Innovation Consortium to help tackle infectious diseases
LifeArc has entered into a partnership with the Liverpool School of Tropical Medicine (LSTM) and will join the LSTM-led Infection…
-
News releasesLifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
-
ArticlesCatriona Crombie talks to Rare Revolution about LifeArc’s investment of more than £100 million into rare disease research by 2030
Catriona discusses why LifeArc is well placed to help overcome some of the obstacles in rare disease research
-
News releasesLifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc’s Board of Trustees as Non-Executive Directors.
-
News releasesNew programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials
-
News releasesLifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
£150,000 grant will fund a study of a biomarker test that could improve outcomes for patients with a rare sarcoma…
-
ArticlesMeet our industrial placement students – class of 2023
Find out what this year’s cohort of industrial placement students gained from the experience.
-
ArticlesTranslational research into children’s rare diseases enters 5th year of collaborative funding
Accelerating research that will have a significant impact on the treatment of children and young people
-
News releasesDr Jason Slingsby joins LifeArc as Chief Business Officer
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.
-
News releasesLifeArc launches £40m funding call to create Translational Rare Disease Centres
Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.
